V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270016138 | 270014063 | 1.6 | 55 | null | 2016-10-09 | 2016-10-10 | BEACOPP | N | Y | 270013410 | BEACOPP |
| 270016139 | 270008604 | 1.8 | 95.6 | Curative (C) | null | 2013-07-17 | Escalated BEACOPP | N | N | 270013459 | BEACOPP |
| 270016140 | 270008605 | null | 48 | Curative (C) | 2013-11-08 | 2013-11-09 | COPP + Dacarbazine | null | N | 270013461 | COPP + DACARBAZINE |
| 270016141 | 270014065 | null | 61.9 | Curative (C) | 2017-10-22 | 2018-01-14 | BEACOPP | 2 | N | 270013464 | BEACOPP |
| 270016142 | 270016704 | 0 | 76 | Curative (C) | 2017-08-08 | 2017-10-09 | HD EuroNet-PHL-C1 COPDAC | N | null | 270013475 | TRIAL |
| 270016143 | 270008609 | 1.62 | 78.1 | Curative (C) | 2018-02-22 | 2018-03-01 | Cetuximab 14 day | N | N | 270013478 | CETUXIMAB |
| 270016144 | 270008611 | 0 | 26.65 | Palliative (P) | 2016-02-29 | 2016-03-21 | HD EuroNet-PHL-C1 COPDAC | Y | N | 270013483 | TRIAL |
| 270016145 | 270008613 | 1.78 | 47.7 | Curative (C) | 2014-01-15 | 2014-03-13 | Cetuximab 14 day | N | N | 270013488 | CETUXIMAB |
| 270016146 | 270008615 | null | 72.6 | Neo-adjuvant (N) | 2013-05-14 | 2013-07-21 | Cetuximab 7 day (>Cycle 2) | N | null | 270013508 | CETUXIMAB |
| 270016147 | 270008618 | 1.83 | 27.8 | Curative (C) | 2014-04-21 | 2014-04-21 | CETUXIMAB | N | N | 270013509 | CETUXIMAB |
| 270016148 | 270008622 | 0 | 97 | Curative (C) | 2014-02-20 | 2014-05-18 | Trial Unspecified | 1 | N | 270013510 | TRIAL |
| 270016149 | 270014072 | 1.71 | 70.5 | Not known (9) | null | 2013-10-16 | HD EuroNet-PHL-C1 COPDAC | N | N | 270013529 | TRIAL |
| 270016150 | 270014072 | 1.65 | null | Curative (C) | 2016-09-18 | 2016-09-26 | BEACOPP-14 | 2 | null | 270013529 | BEACOPP |
| 270016151 | 270020142 | null | 75.1 | null | 2014-04-29 | 2014-05-14 | Cetuximab 7 day (>Cycle 2) | 02 | null | 270013544 | CETUXIMAB |
| 270016152 | 270008627 | 1.6 | null | null | 2017-01-05 | 2017-03-24 | BEACOPP | 2 | N | 270013549 | BEACOPP |
| 270016153 | 270008629 | 1.7 | null | Curative (C) | 2016-11-17 | 2016-11-21 | HD EuroNet-PHL-C1 Relapsed IEP | Y | N | 270013568 | TRIAL |
| 270016154 | 270008632 | 0 | 79.299 | Curative (C) | 2014-08-12 | 2014-08-13 | HD EuroNet-PHL-C1 Relapsed IEP | N | null | 270013576 | TRIAL |
| 270016155 | 270008632 | 0 | null | Curative (C) | 2015-09-19 | 2015-09-19 | COPP + Dacarbazine | N | N | 270013576 | COPP + DACARBAZINE |
| 270016156 | 270008632 | 1.74 | 75.7 | Palliative (P) | 2015-03-28 | 2015-09-14 | Cetuximab 7 day (>Cycle 2) | N | null | 270013576 | CETUXIMAB |
| 270016157 | 270016711 | 0 | 85 | Palliative (P) | 2013-07-23 | 2013-07-24 | COPP + Dacarbazine | 02 | N | 270013582 | COPP + DACARBAZINE |
| 270016158 | 270016711 | 0 | null | Curative (C) | 2017-03-18 | 2017-05-21 | COPP + Dacarbazine | N | N | 270013582 | COPP + DACARBAZINE |
| 270016159 | 270008636 | 1.69 | null | null | null | 2017-05-26 | BEACOPP-14 | N | N | 270013592 | BEACOPP |
| 270016160 | 270008638 | null | 38.2 | Palliative (P) | 2017-11-19 | 2017-12-16 | CETUXIMAB | N | N | 270013596 | CETUXIMAB |
| 270016161 | 270008640 | 1.75 | 49.1 | Neo-adjuvant (N) | 2015-11-01 | 2016-06-06 | Cetuximab 14 day | 02 | N | 270013636 | CETUXIMAB |
| 270016162 | 270014080 | 1.78 | 25.1 | Curative (C) | 2017-07-19 | 2018-05-12 | CETUXIMAB | N | N | 270013636 | CETUXIMAB |
| 270016163 | 270008642 | 0 | 96 | Curative (C) | 2016-04-11 | 2016-07-12 | BEACOPP | N | null | 270013645 | BEACOPP |
| 270016164 | 270016715 | 1.6 | 45.2 | Curative (C) | 2017-01-02 | 2017-01-06 | Escalated BEACOPP | 02 | null | 270013662 | BEACOPP |
| 270016165 | 270020052 | 0 | 37.4 | null | 2017-04-13 | 2017-06-08 | COPP + Dacarbazine | N | N | 270013711 | COPP + DACARBAZINE |
| 270016166 | 270008643 | 1.75 | 63.1 | Curative (C) | 2017-08-21 | 2017-09-15 | CETUXIMAB | N | null | 270013715 | CETUXIMAB |
| 270016167 | 270008644 | null | 92.8 | Adjuvant (A) | 2013-05-21 | 2013-05-23 | COPP + Dacarbazine | 2 | N | 270013731 | COPP + DACARBAZINE |
| 270016168 | 270014084 | 0 | 80 | null | null | 2017-08-31 | Escalated BEACOPP | N | null | 270013753 | BEACOPP |
| 270016169 | 270008649 | null | 85 | Not known (9) | 2015-04-13 | 2015-05-04 | Cetuximab 7 day (>Cycle 2) | 2 | Y | 270013762 | CETUXIMAB |
| 270016170 | 270008653 | 1.68 | 79.1 | Curative (C) | 2016-09-05 | 2016-10-05 | Cetuximab 7 day (>Cycle 2) | 02 | null | 270013773 | CETUXIMAB |
| 270016171 | 270019117 | 1.71 | 70.1 | Adjuvant (A) | 2016-08-07 | 2016-08-12 | Trial Unspecified | Y | N | 270013792 | TRIAL |
| 270016172 | 270014088 | null | 101.2 | Curative (C) | 2013-07-18 | 2014-02-05 | HD EuroNet-PHL-C1 COPDAC | N | Y | 270013828 | TRIAL |
| 270016173 | 270014088 | 1.86 | 73.8 | Curative (C) | 2016-07-12 | 2017-02-27 | Cetuximab 14 day | 02 | null | 270013828 | CETUXIMAB |
| 270016174 | 270014089 | null | 66.2 | null | 2016-10-20 | 2017-02-01 | COPP + Dacarbazine | null | N | 270013840 | COPP + DACARBAZINE |
| 270016175 | 270008661 | 1.7 | 45.2 | null | 2014-10-11 | 2014-10-11 | CETUXIMAB | N | N | 270013844 | CETUXIMAB |
| 270016176 | 270008662 | 1.79 | null | Curative (C) | 2014-02-25 | 2014-03-10 | Escalated BEACOPP | 2 | Y | 270013854 | BEACOPP |
| 270016177 | 270008664 | null | 41.7 | null | 2013-05-16 | 2013-07-18 | Escalated BEACOPP | N | N | 270013881 | BEACOPP |
| 270016178 | 270008666 | 1.75 | 82.6 | Palliative (P) | 2012-03-05 | 2014-05-23 | Trial Unspecified | 02 | null | 270013890 | TRIAL |
| 270016179 | 270016722 | 1.89 | 72.5 | Palliative (P) | 2018-04-07 | 2018-04-11 | COPP + Dacarbazine | null | N | 270013902 | COPP + DACARBAZINE |
| 270016180 | 270008670 | 1.51 | 39.9 | Not known (9) | 2015-07-23 | 2015-08-05 | Escalated BEACOPP | N | N | 270013928 | BEACOPP |
| 270016181 | 270016723 | null | null | null | null | 2015-03-31 | Cetuximab 7 day (>Cycle 2) | N | N | 270013931 | CETUXIMAB |
| 270016182 | 270008672 | 1.68 | 38.4 | Palliative (P) | 2017-04-07 | 2017-04-14 | Cetuximab 7 day (Cycle 1) | 2 | N | 270013934 | CETUXIMAB |
| 270016183 | 270019119 | 1.75 | 74 | Curative (C) | 2014-08-27 | 2014-10-23 | COPP + Dacarbazine | N | N | 270013943 | COPP + DACARBAZINE |
| 270016184 | 270008675 | 1.69 | 57.65 | Disease modification (D) | 2017-05-16 | 2017-06-06 | BEACOPP-14 | null | N | 270013967 | BEACOPP |
| 270016185 | 270008675 | null | 58.6 | Curative (C) | 2012-10-27 | 2014-04-10 | CETUXIMAB | null | null | 270013967 | CETUXIMAB |
| 270016186 | 270008677 | 1.77 | 28.9 | Curative (C) | 2017-09-28 | 2017-11-08 | Cetuximab 7 day (>Cycle 2) | N | N | 270013969 | CETUXIMAB |
| 270016187 | 270008680 | 1.79 | 49.1 | Palliative (P) | null | 2014-07-14 | HD EuroNet-PHL-C1 COPDAC | N | N | 270013976 | TRIAL |